Retinal ganglion cell loss in kinesin-1 cargo Alcadein α deficient mice
Yuki Nakano, Kazuyuki Hirooka, Yoichi Chiba, Masaki Ueno, Daiki Ojima, Md Razib Hossain, Hiroo Takahashi, Tohru Yamamoto, Yoshiaki Kiuchi, Yuki Nakano, Kazuyuki Hirooka, Yoichi Chiba, Masaki Ueno, Daiki Ojima, Md Razib Hossain, Hiroo Takahashi, Tohru Yamamoto, Yoshiaki Kiuchi
Abstract
Maintenance of retinal ganglion cells (RGCs) activity is relied on axonal transport conveying materials required for their survival such as neurotrophic factors. Kinesin-1 undergoes anterograde transport in axons, and Alcadein α (Alcα; also called calsyntenin-1) is a major cargo adaptor protein that can drive kinesin-1 to transport vesicles containing Alcα. The long-term effects of Alcα-deficiency on retinal morphology and survival of RGCs during postnatal development were examined in Alcα knockout mice. At 1.5, 3, 6, and 15 months postnatal, the number of retrogradely labeled RGCs was determined in flat-mounted retinas of Alcα-deficient and wild-type mice. Retinal damage was assessed histologically by determining the retinal thickness. Intraocular pressure (IOP) was measured with a Tonolab tonometer. At 1.5 months postnatal, the number of retrogradely labeled RGCs was not different between wild-type and Alcα-deficient mice. However, at 3, 6, and 15 months postnatal, the number of RGCs was significantly lower in Alcα deficient mice than those of wild-type mice (143 ± 41.1 cells/mm2 vs. 208 ± 28.4 cells/mm2, respectively, at 3 months; P < 0.01). No differences were seen in retinal thickness or IOP between the two types of mice at any postnatal age. Alcα-deficient mice showed spontaneous loss of RGCs but no elevation in IOP. These mice mimic normal-tension glaucoma and will be useful for investigating the mechanism of neurodegeneration in this disorder and for developing treatments for RGC loss that does not involve changes in IOP.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
- Calkins DJ. Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin Eye Res. 2012;31:702–719. doi: 10.1016/j.preteyeres.2012.07.001.
- Micera A, et al. Differential protein expression profiles in glaucomatous trabecular meshwork: an evaluation study on a small primary open angle glaucoma population. Adv. Ther. 2016;33:252–267. doi: 10.1007/s12325-016-0285-x.
- Almasieh M, Wilson AM, Morquette B, Cueva, Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin Eye Res. 2012;31:152–181. doi: 10.1016/j.preteyeres.2011.11.002.
- Millecamps S, Julien J-P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 2013;14:161–176. doi: 10.1038/nrn3380.
- Fahy ET, Chrysostomou V, Crowston JG. Mini-review: impaired axonal transport and glaucoma. Curr. Eye Res. 2016;41:273–283.
- Verhey KJ, Kaul N, Soppina V. Kinesin assembly and movement in cells. Annu Rev. Biophys. 2011;40:267–288. doi: 10.1146/annurev-biophys-042910-155310.
- Hintsch G, et al. The calsyntenins—a family of postsynaptic membrane proteins with distinct neuronal expression patterns. Mol. Cell Neurosci. 2002;21:393–409. doi: 10.1006/mcne.2002.1181.
- Araki Y, et al. Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein mediated stabilization of amyloid β-protein precursor metabolism. J. Biol. Chem. 2003;278:49448–49458. doi: 10.1074/jbc.M306024200.
- Araki Y, et al. The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J. 2007;26:1475–1486. doi: 10.1038/sj.emboj.7601609.
- Kawano T, et al. A small peptide sequence is sufficient for initiating kinesin-1 activation through part of TPR region of KLC1. Traffic. 2012;13:834–848. doi: 10.1111/j.1600-0854.2012.01350.x.
- Yip YY, et al. The light chains of kinesin-1 are autoinhibited. Proc. Natl Acad. Sci. USA. 2016;113:2418–2423. doi: 10.1073/pnas.1520817113.
- Vagnoni A, et al. Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production. Hum. Mol. Genet. 2012;21:2845–2854. doi: 10.1093/hmg/dds109.
- Gotoh, N. et al. APP amyloidogenic processing is enhanced in the brains of Alcadein α-deficient mice. Under submission.
- Yagi T, et al. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 1993;214:70–76. doi: 10.1006/abio.1993.1458.
- Tian E, Kimura C, Takeda N, Aizawa S, Matsui I. Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. Dev. Biol. 2002;242:204–223. doi: 10.1006/dbio.2001.0531.
- Ishikawa T, et al. IgSF molecule MDGA1 is involved in radial migration and positioning of a subset of cortical upper-layer neurons. Dev. Dyn. 2011;240:96–107. doi: 10.1002/dvdy.22496.
- Maruta C, et al. Constitutive cleavage of the single-pass transmembrane protein alcadeinα prevents aberrant peripheral retention of Kinesin-1. PLoS ONE. 2012;7:e43058. doi: 10.1371/journal.pone.0043058.
- Quina LA, et al. Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways. J. Neurosci. 2005;25:11595–11604. doi: 10.1523/JNEUROSCI.2837-05.2005.
- Nadal-Nicolás FM, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol. Vis. Sci. 2009;50:3860–3868. doi: 10.1167/iovs.08-3267.
- Alther TA, Domanitskaya E, Stoeckli ET. Calsyntenin 1-mediated trafficking of axon guidance receptors regulates the switch in axonal responsiveness at a choice point. Development. 2016;143:994–1004. doi: 10.1242/dev.127449.
- Liu H, Thurig S, Mohamed O, Dufort D, Wallace VA. Mapping canonical Wnt signaling in the developing and adult retina. Invest Ophthalmol. Vis. Sci. 2009;47:5088–5097. doi: 10.1167/iovs.06-0403.
- Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 2006;12:1005–1015.
- Gupta N, Fong J, Ang LC, Yücel YH. Retinal tau pathology in human glaucomas. Can. J. Ophthalmol. 2008;43:53–60. doi: 10.3129/i07-185.
- Tsolaki F, et al. Alzheimer’s disease and primary open-angle glaucoma: is there a connection? Clin. Ophthalmol. 2011;5:887–890. doi: 10.2147/OPTH.S22485.
- Nucci C, et al. Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system. Prog. Brain Res. 2015;221:49–65. doi: 10.1016/bs.pbr.2015.04.010.
- Wang J, et al. Development and expression of amyloid-β peptide 42 in retinal ganglion cells in rat. Anat. Rec. 2011;294:1401–1405. doi: 10.1002/ar.21438.
- Kipfer-Kauer A, McKinnon SJ, Frueh BE, Goldblum D. Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes. Curr. Eye Res. 2010;35:828–834. doi: 10.3109/02713683.2010.494240.
- Zott B, et al. A vicious cycle of β amyloid-dependent neuronal hyperactivation. Science. 2019;365:559–565. doi: 10.1126/science.aay0198.
- Almasieh M, Wilson AM, Morquette B, Cueva, Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin Eye Res. 2012;31:152–161. doi: 10.1016/j.preteyeres.2011.11.002.
- Sane JR, Masland RH. The types of retinal ganglion cells: current status and implications for neuronal classification. Annu Rev. Neurosci. 2015;38:221–246. doi: 10.1146/annurev-neuro-071714-034120.
Source: PubMed